The standard maximum oral dose of hydralazine is 300 mg per day, split across multiple doses. Most prescribers, however, keep patients at or below 200 mg per day because the risk of a serious autoimmune side effect climbs steeply above that threshold. How much you actually end up taking depends on several factors that are surprisingly individual, including your genetic makeup, kidney function, and whether you are taking hydralazine for high blood pressure or heart failure.
Standard Oral Dosing
Hydralazine is typically started at a low dose and increased gradually. A common starting regimen is 10 mg taken four times a day for the first two to four days, then 25 mg four times a day for the rest of the first week or so. From there, the dose is adjusted based on blood pressure response. Most people end up somewhere between 100 and 200 mg per day, divided into two to four doses. The labeled ceiling is 300 mg per day, but reaching that level is unusual because side effects become more likely and because other blood pressure medications are usually added before pushing hydralazine that high.
Hydralazine’s effect on blood pressure wears off relatively quickly, which is why it is usually dosed multiple times a day rather than once. The drug works by relaxing the smooth muscle in blood vessel walls. Research in animal models has shown that its main action involves blocking the release of calcium inside vascular smooth muscle cells, which prevents those cells from contracting and narrowing the vessel.1PubMed Central. Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery In smaller resistance arteries, a separate mechanism kicks in at clinically relevant concentrations: hydralazine triggers the release of a substance called prostacyclin from the vessel lining, which also promotes relaxation.2PubMed. Mechanism of hydralazine-induced relaxation in resistance arteries during pregnancy In larger arteries, the relaxation appears to happen independently of the vessel lining altogether.3PubMed. Hydralazine dilates large epicardial coronary arteries in conscious dogs through an endothelium-independent mechanism
Why Your Genetics Affect the Dose You Need
One of the most striking things about hydralazine is how much your genetic acetylator status influences its effect. Your liver breaks down hydralazine through an enzyme called NAT2, and people fall into roughly two camps: “slow acetylators,” whose enzyme works at a leisurely pace, and “rapid acetylators,” whose enzyme chews through the drug quickly. This is not a small difference. Studies using precise assay methods have found that slow acetylators absorb roughly 30 to 35 percent of an oral dose into their bloodstream, while rapid acetylators absorb only about 10 to 16 percent of the same dose.4Clinical Pharmacokinetics. Clinical Pharmacokinetics of Hydralazine That means a rapid acetylator may need two or three times more hydralazine to get the same blood pressure drop.
Clinical data bear this out. In one study, 81 percent of rapid acetylators needed 200 mg per day, compared with only 38 percent of slow acetylators. Even with those higher doses, blood pressure was controlled in just 27 percent of rapid acetylators versus 65 percent of slow acetylators.5PubMed. Should the acetylator phenotype be determined when prescribing hydralazine for hypertension? The relationship between acetylator status and hydralazine blood levels has been confirmed across a large body of work: a review found that fourteen out of fifteen studies showed a significant link, always in the same direction.6PubMed Central. Genotype-Guided Hydralazine Therapy
Clinical pharmacogenetics guidelines now formally recognize this. A guideline from the Clinical Pharmacogenetics Implementation Consortium notes that slow acetylators (termed “NAT2 poor metabolizers”) are predicted to have higher plasma hydralazine levels, which can lead to both stronger blood pressure lowering and a greater chance of adverse effects, including drug-induced lupus.7PubMed Central. Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy In practice, most patients do not get genotyped before starting hydralazine. But if you are a slow acetylator and you are taking a high dose, you may be getting far more active drug in your bloodstream than your prescriber expects.
How Food Changes Absorption
Whether you take hydralazine with food or on an empty stomach can meaningfully shift how much drug reaches your bloodstream, though the research findings are not entirely consistent. An early study found that food enhanced hydralazine’s bioavailability two- to threefold, regardless of whether coated or uncoated tablets were used.8PubMed. Enhancement of hydralazine bioavailability by food A later study confirmed that food intake does enhance both the bioavailability and the blood-pressure-lowering effect.9PubMed. Concomitant food intake does enhance the bioavailability and effect of hydralazine A broader pharmacokinetic review also noted that food may enhance bioavailability.4Clinical Pharmacokinetics. Clinical Pharmacokinetics of Hydralazine
However, one study found the opposite: peak blood hydralazine levels dropped by about 46 percent after food, and the blood-pressure-lowering effect fell by roughly 42 percent. The authors suggested that food might speed the breakdown of hydralazine in the bloodstream and recommended patients take their doses at a consistent time relative to meals.10PubMed. Effect of food on blood hydralazine levels and response in hypertension The discrepancy likely reflects differences in assay methods and study design, but the practical takeaway is consistent: pick a pattern and stick with it. If you sometimes take hydralazine with a meal and sometimes on an empty stomach, you are essentially giving yourself a different dose each time.
Kidney Disease and Drug Accumulation
Your kidneys play a larger role in hydralazine’s behavior than many people realize. In patients with impaired kidney function, the drug’s half-life in the body increases dramatically. A study of patients with varying degrees of kidney impairment found that as kidney filtration rate dropped, the drug stuck around longer. In one patient whose kidneys were filtering at only about a sixth of the normal rate, hydralazine’s half-life reached nearly 16 hours, compared with roughly 1.7 to 3 hours in healthy volunteers. Among patients on long-term hydralazine, those with severely reduced kidney function showed clear drug accumulation at the same daily doses.11PubMed. Studies on hydralazine. II. Elimination rate and steady-state concentration in patients with impaired renal function
This accumulation is clinically relevant. If the drug is hanging around five to ten times longer than expected, a “normal” daily dose can produce blood levels that look more like a higher dose. People with significant kidney disease may need less hydralazine overall, and their prescribers usually adjust accordingly. The risk is highest in patients with a filtration rate below about 30 mL per minute, where the buildup becomes most pronounced.
The Lupus Risk and Why 200 mg Is a Practical Ceiling
The most feared long-term side effect of hydralazine is drug-induced lupus, an autoimmune condition where the body’s immune system begins attacking its own tissues. It is distinct from naturally occurring lupus but can produce real symptoms, including joint pain, skin rashes, fever, and, in some cases, fluid buildup around the heart. A case report documented a patient who developed recurring pericardial effusion after taking hydralazine for roughly one and a half to two years.12PubMed Central. Hydralazine Induced Lupus Syndrome Presenting with Recurrent Pericardial Effusion and a Negative Antinuclear Antibody That case was unusual because the standard blood test used to screen for lupus came back negative, illustrating that the diagnosis is not always straightforward.
The risk of drug-induced lupus increases with both dose and duration. This is the main reason many prescribers treat 200 mg per day as the functional maximum, even though the label permits 300 mg. Slow acetylators face higher risk because more active drug reaches their bloodstream at any given dose, as described above. There is also a related but more serious concern: hydralazine-associated vasculitis, an inflammation of blood vessels. A large study found that higher daily doses of hydralazine (above 40 mg per day) were associated with about a 28 percent increase in the risk of vasculitis compared with lower doses.13JAMA Network Open. Hydralazine Use and Risk of Vasculitis In a separate analysis, the median daily dose among patients who developed hydralazine-associated vasculitis was 150 mg, and the median time to onset was about 34 months.14Arthritis & Rheumatology. Long Term Outcome of Hydralazine-Associated Vasculitis
Drug-induced lupus and vasculitis generally improve after stopping hydralazine, though recovery can take weeks to months. The key point for dosing is that pushing above 200 mg per day adds only modest additional blood pressure benefit in most people while meaningfully increasing the chance of triggering an immune-mediated reaction, especially over months or years of use.
Why Hydralazine Is Almost Always Paired with Other Medications
You will rarely see hydralazine prescribed alone. When it lowers blood pressure by relaxing blood vessels, the body’s nervous system responds by speeding up the heart and retaining fluid, a compensation that can blunt the drug’s effect over time. This phenomenon, sometimes called pseudotolerance, is managed by adding a beta-blocker (to counteract the heart rate increase) and a diuretic (to prevent fluid retention). A clinical trial found that blood pressure was controlled in 31 of 37 patients using this triple combination, and a subsequent crossover comparing hydralazine to placebo within that regimen confirmed its contribution.15PubMed. Hydrallazine with beta-blocker and diuretic in the treatment of hypertension. A double-blind crossover study The same study noted that starting the beta-blocker first was advisable, given the frequency of hydralazine-related side effects.
This means the total daily dose you need of hydralazine is shaped partly by which companion drugs you are taking. A well-chosen beta-blocker and diuretic can make a moderate dose of hydralazine much more effective than a high dose of hydralazine alone.
Different Dosing for Heart Failure
Hydralazine is also used in heart failure, but the context and dosing logic are different from its use in straightforward high blood pressure. The landmark application is the combination of hydralazine with isosorbide dinitrate, sold as the fixed-dose product BiDil. In a major trial of Black patients with advanced heart failure, the combination of hydralazine and isosorbide dinitrate added to standard therapy reduced the death rate by 43 percent compared with placebo, and the trial was stopped early because the benefit was so clear.16PubMed. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure Earlier work had shown that the two drugs together produced greater improvements in cardiac output and exercise capacity than either drug alone.17PubMed Central. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure
In the heart failure setting, the target dose of hydralazine within the fixed-dose combination is typically 225 mg per day (75 mg three times daily), paired with isosorbide dinitrate. The goal is not just blood pressure lowering but reducing the workload on the heart by opening both arteries and veins. If you are taking hydralazine for heart failure, your prescriber is following a different dosing framework than someone using it purely for hypertension.
Intravenous Hydralazine in Emergencies
When blood pressure needs to come down urgently, such as during severe preeclampsia in pregnancy or a hypertensive emergency in a hospital setting, hydralazine can be given intravenously or by intramuscular injection. A typical IV dose is 5 to 10 mg, administered slowly over 10 to 15 minutes, and repeated every 20 to 30 minutes if needed.18PubMed Central. Intravenous Hydralazine for Blood Pressure Management in the Hospitalized Patient: Its Use is Often Unjustified In a randomized trial comparing emergency antihypertensive drugs for severe preeclampsia, each dose of IV hydralazine was 10 mg diluted in saline, given up to three times within an hour.19PubMed Central. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial
Intravenous hydralazine bypasses the gut and the first-pass metabolism that makes oral dosing so dependent on acetylator status. After IV administration, the acetylator phenotype is not a major factor in how the drug is cleared.4Clinical Pharmacokinetics. Clinical Pharmacokinetics of Hydralazine This makes IV dosing somewhat more predictable than oral dosing, though the response can still be erratic. One of hydralazine’s known drawbacks in emergency settings is unpredictable hypotension, where blood pressure drops further or faster than expected.20American Journal of Health-System Pharmacy. Pharmacotherapeutic options for the treatment of preeclampsia
Hydralazine in Pregnancy
Hydralazine has been one of the most widely used blood pressure drugs in pregnancy, particularly for preeclampsia and eclampsia. It has a long safety track record in terms of not being directly toxic to the fetus, which is why it remains in use even as alternatives have gained ground. However, a meta-analysis of trials comparing hydralazine to other antihypertensives in severe pregnancy hypertension found that hydralazine was associated with more maternal hypotension, more cesarean sections, more placental abruption, and more adverse effects on fetal heart rate. The authors concluded that the evidence does not support using hydralazine as a first-line choice for severe hypertension in pregnancy.21PubMed Central. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis Labetalol and nifedipine have increasingly taken that role. Still, hydralazine remains an option, particularly when other drugs are unavailable or contraindicated.
Pediatric Use
In children and adolescents, hydralazine is sometimes given intravenously in hospital settings for acute hypertension. Dosing is weight-based rather than fixed. A study of 141 IV hydralazine doses in hospitalized children found a median dose of 0.10 mg per kilogram of body weight. The drug reduced blood pressure by an average of about 19 percent. Nearly a third of children had what the researchers classified as an excessive response, where blood pressure dropped more than intended, and higher doses were linked to greater odds of that happening.22PubMed. Intravenous Hydralazine in Hospitalized Children and Adolescents with Hypertension This underscores a theme across all ages: hydralazine’s response is hard to predict, and starting low is prudent.
Older Adults and Fall Risk
In older patients, any blood-pressure-lowering medication carries the risk of making someone dizzy when they stand up, and hydralazine is no exception. A review of antihypertensive safety in older adults noted that all classes of blood pressure drugs, including direct vasodilators like hydralazine, can predispose older patients to symptomatic drops in blood pressure when standing or after eating, potentially leading to fainting or falls.23PubMed. Treating hypertension in older adults: safety considerations Because hydralazine’s effect can be unpredictable, and because older adults are more likely to have reduced kidney function that slows drug clearance, the practical maximum dose in this group is often lower than the textbook ceiling.
What Happens in an Overdose
Hydralazine overdose essentially amplifies the drug’s normal pharmacological action to a dangerous degree, producing severe low blood pressure, rapid heart rate, fainting, and nausea.24PubMed. Electrocardiographic Changes Following Acute Hydralazine Overdose In at least one documented case of acute overdose in a young adult, the patient developed alarming electrocardiogram changes that looked like a heart attack, along with mild low blood pressure and acidic blood chemistry. The patient was managed conservatively in an intensive care unit and recovered fully as the drug cleared the system.25PubMed. Acute hydralazine overdose: marked ECG abnormalities in a young adult There is no specific antidote for hydralazine overdose; treatment focuses on IV fluids, vasopressors if blood pressure is dangerously low, and monitoring until the drug is metabolized. The relatively short half-life of hydralazine in people with normal kidney function works in the patient’s favor during an acute overdose.